Clinical Trials Directory

Trials / Completed

CompletedNCT06046352

Symptom Burden Guiding Invasive Electrophysiological Study in Paroxysmal Supraventricular Tachycardia

Status
Completed
Phase
Study type
Observational
Enrollment
711 (actual)
Sponsor
Hospital Universitario 12 de Octubre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

BELIEVE-SVT is a European multi-centre, retrospective registry in tertiary hospitals performing electrophysiological study in patients with palpitations considered clinically suggestive of paroxysmal supraventricular tachycardia by a cardiologist and without electrocardiographic documentation of tachycardia or preexcitation. Clinical characteristics, results of electrophysiological study and ablation, complications, and clinical outcomes during follow-up will be analysed.

Detailed description

The "Symptom Burden As Guiding Principle For Invasive Electrophysiological Study In Paroxysmal Supraventricular Tachycardia (Believe-SVT)" study was a multi-centre, retrospective, observational registry carried out in tertiary European hospitals. Inclusion criteria were: symptoms that were considered suggestive of paroxysmal supraventricular tachycardia by a cardiologist and/or cardiac electrophysiologist; absence of any sort of electrocardiographic tracing during episodes (including wearables and other single lead devices), and having undergone an electrophysiological study aimed at the diagnosis of paroxysmal supraventricular tachycardia.

Conditions

Interventions

TypeNameDescription
PROCEDUREElectrophysiological study (and ablation when appropriate)Electrophysiological study (and ablation when appropriate)

Timeline

Start date
2019-12-17
Primary completion
2021-11-02
Completion
2022-06-01
First posted
2023-09-21
Last updated
2023-09-21

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06046352. Inclusion in this directory is not an endorsement.